Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-24-020996

Chief Financial Officer gave up 636 shares (to pay taxes)

  • Chief Financial Officer acquired 2,712 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Foster Jonathan P. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-20 Exercise or conversion : show line 1 in the form +2,712 8,723 D
2024-06-20 Shares withheld for taxes : show line 2 in the form −636 $3.78 $2,404 8,087 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-20 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,712 69,166 D
Loading xslF345X05/rdgdoc.xml…